You must be 21+ years old to visit our website. Select your preference below.
Important Disclaimer: This product is sold strictly for research and laboratory use only and is not intended for human or animal consumption, medical, diagnostic, or therapeutic purposes.
These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.
$74.99
8 in stock (can be backordered)
CJC-1295 No DAC is a short-acting GHRH-related peptide commonly studied in research involving:
The commercial name “CJC-1295 No DAC” is commonly used for a modified GHRH(1–29)-related peptide that lacks the Drug Affinity Complex responsible for albumin binding. It is studied as a GHRH-receptor agonist that acts on pituitary somatotroph cells, initiating cyclic AMP, protein kinase A, and calcium-dependent signaling associated with growth hormone release.
Without the albumin-binding DAC modification, the research material is expected to have a shorter duration of exposure than authentic CJC-1295 with DAC. This makes it useful in experimental comparisons of brief GHRH-receptor activation, pulsatile growth hormone signaling, and downstream IGF-1-associated pathways.
“CJC-1295 No DAC” is not used consistently across the research-material market and should not automatically be treated as structurally identical to published CJC-1295 with DAC. The exact sequence, substitutions, terminal modification, counterion, and molecular mass must be confirmed against the AF Peptides product-specific COA before those specifications are published.
IMPORTANT DISCLAIMER — FOR LABORATORY RESEARCH USE ONLY
This product is intended exclusively for laboratory research purposes. It is not intended for human or animal consumption or for human or veterinary use, administration, ingestion, injection, inhalation, implantation, topical application, compounding, medical use, diagnostic use, or therapeutic use.
This product is not approved by the U.S. Food and Drug Administration for human or veterinary use. It is not intended to diagnose, treat, cure, mitigate, or prevent any disease or medical condition. AF Peptides makes no representation regarding its safety, effectiveness, or suitability for any clinical, therapeutic, diagnostic, personal, or household application.
